Related Experiment Video

Updated: May 30, 2026

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
10:44

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

Published on: May 5, 2023

In vitro and in vivo silencing of the androgen receptor

Helen Cheng1, Eric Leblanc, Paul S Rennie

  • 1Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada. hcheng@prostatecentre.com

Methods in Molecular Biology (Clifton, N.J.)
|July 29, 2011
PubMed

Insights

This study engineered prostate cancer cells to control androgen receptor (AR) levels using doxycycline. This allows researchers to investigate the effects of reducing AR in prostate cancer progression and therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The androgen receptor (AR) is crucial for prostate cancer progression, including the transition to castration-resistant prostate cancer (CRPC).
  • Targeting AR is a key therapeutic strategy for advanced prostate cancer.

Purpose of the Study:

  • To develop and utilize engineered prostate cancer cell lines for studying the functional impact of androgen receptor (AR) knockdown.
  • To investigate the in vitro and in vivo consequences of AR downregulation in prostate cancer models.

Main Methods:

  • Generation of LNCaP and C4-2 human prostate cancer cell sublines.
  • Stable integration of a doxycycline (DOX)-inducible short hairpin RNA (shRNA) targeting the androgen receptor (AR).
  • Assessment of AR knockdown effects on cancer cell behavior both in vitro and in vivo.

Main Results:

  • Successfully created cell lines with inducible AR knockdown using DOX.
  • Established a model system to analyze the effects of AR suppression on prostate cancer progression.
  • Provided a platform for further research into AR-targeted therapies.

Conclusions:

  • Engineered prostate cancer cell lines offer a valuable tool for dissecting the role of AR in disease progression.
  • This system facilitates the study of AR's impact on the transition to castration-resistant disease.
  • The developed methodology supports the investigation of novel AR-targeting therapeutic strategies.

More Related Videos

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses08:36

Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses

Published on: October 24, 2019

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...